Early studies suggested that after withdrawal from FGAs, approximately 33% to 53% of patients experience worsening of dyskinesias initially, while 36% to 55% may show improvement over time.Reference Egan, Apud and Wyatt 132 In a meta-analysis, Soares and McGrath reported that 37.3% of patients assigned to placebo across studies showed some improvement of TD, but concluded that evidence was insufficient to support antipsychotic drug cessation or dose reduction in view of the risk for psychotic relapse.Reference Soares and McGrath 133 While recent surveys suggest as few as 2% to 5% of patients show resolution of TD without specific treatment even when followed-up for a few years after antipsychotic withdrawal,Reference Zutshi, Cloud and Factor 134 , Reference Glazer, Moore, Schooler, Brenner and Morgenstern 135 earlier studies reported remission a few months to years after drug cessation in 50% to 75% of patients provided that TD was detected early.Reference Jeste, Potkin, Sinha, Feder and Wyatt 83 , Reference Quitkin, Rifkin, Gochfeld and Klein 136 - Reference Casey, Gerlach, Casey and Gardos 138 These early reports suggest that further studies of antipsychotic cessation in nonpsychotic patients as a management option for new-onset cases of TD are needed
When the amount of 4a was increased to 1.2 equiv., para -aminated product ( 5a ) was obtained in 38% yield
However, toxins such as environmental pollutants, drugs, and chemicals in food can impair the methylation pathway by interfering with the enzymes involved in the process and depleting the body's stores of crucial components like SAMe and methionine
Sattler, F
